UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-QSB
(Mark One)
X QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
For the quarterly period ended September 30, 2006
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ____________ to ____________
Commission File Number: 0-21802
N-VIRO INTERNATIONAL CORPORATION
(Exact name of small business issuer as specified in its charter)
Delaware 34-1741211
(State or other jurisdiction of (IRS Employer Identification No.)
incorporation or organization)
3450 W. Central Avenue, Suite 328
Toledo, Ohio 43606
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (419) 535-6374
Check whether the issuer (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or
for such shorter period that the registrant was required to file such reports),
and (2) has been subject to the filing requirements for the past 90 days.
Yes X No
----
Indicate by check mark whether the registrant is a shell company (as
defined in Rule 12b-2 of the Exchange Act). Yes No X
----
As of November 3, 2006, 3,728,059 shares of N-Viro International
Corporation $ .01 par value common stock were outstanding.
Transitional Small Business Disclosure Format (check one): Yes No X
----
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements
N-Viro International Corporation
Consolidated Statements of Operations
(Unaudited)
Three Months Ended Sept. 30 Nine Months Ended Sept. 30
------------------------ ------------------------
2006 2005 2006 2005
----------- ----------- ----------- -----------
Revenues $ 884,859 $ 947,963 $2,866,015 $3,102,449
Cost of revenues 596,609 688,751 1,827,741 2,260,547
----------- ----------- ----------- -----------
Gross Profit 288,250 259,212 1,038,274 841,902
Operating expenses:
Selling, general and administrative 444,720 287,851 1,357,912 1,004,931
----------- ----------- ----------- -----------
Operating loss (156,470) (28,639) (319,638) (163,029)
Nonoperating income (expense):
Interest income 2,408 2,272 6,690 4,420
Interest expense (3,211) (5,560) (11,896) (21,412)
Loss from equity investment in joint venture - (32,058) - (155,584)
----------- ----------- ----------- -----------
(803) (35,346) (5,206) (172,576)
----------- ----------- ----------- -----------
Loss before income taxes (157,273) (63,985) (324,844) (335,605)
Federal and state income taxes - - - -
----------- ----------- ----------- -----------
Net loss $ (157,273) $ (63,985) $ (324,844) $ (335,605)
=========== =========== =========== ===========
Basic and diluted loss per share $ (0.04) $ (0.02) $ (0.09) $ (0.10)
=========== =========== =========== ===========
Weighted average common shares outstanding - basic and diluted 3,719,543 3,528,146 3,707,180 3,492,054
=========== =========== =========== ===========
See Notes to Consolidated Financial Statements
N-Viro International Corporation
Consolidated Balance Sheets
September 30, 2006 (Unaudited) December 31, 2005
------------------------------- -------------------
ASSETS
- -----------------------------------------------------------------
CURRENT ASSETS
Cash and cash equivalents:
Unrestricted $ 178,445 $ 224,447
Restricted 130,626 128,133
Trade Receivables, net 564,171 600,180
Prepaid expenses and other current assets 178,478 204,360
------------------------------- -------------------
Total current assets 1,051,720 1,157,120
Property and Equipment, Net 605,590 382,085
Intangible and Other Assets, Net 814,935 1,037,693
------------------------------- -------------------
$ 2,472,245 $ 2,576,898
=============================== ===================
LIABILITIES AND STOCKHOLDERS' EQUITY
- -----------------------------------------------------------------
CURRENT LIABILITIES
Current maturities of long-term debt $ 79,710 $ 80,860
Line-of-credit 25,000 80,000
Accounts payable 838,625 833,447
Deferred revenue 3,675 -
Accrued liabilities 202,766 204,109
------------------------------- -------------------
Total current liabilities 1,149,776 1,198,416
Long-term debt, less current maturities 174,405 21,209
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY
Common stock, $.01 par value; authorized 7,000,000 shares; issued
3,851,559 in 2006 and 3,814,159 in 2005 38,516 38,141
Additional paid-in capital 15,406,091 15,290,831
Accumulated deficit (13,611,653) (13,286,809)
------------------------------- -------------------
1,832,954 2,042,163
Less treasury stock, at cost, 123,500 shares 684,890 684,890
------------------------------- -------------------
Total stockholders' equity 1,148,064 1,357,273
------------------------------- -------------------
$ 2,472,245 $ 2,576,898
=============================== ===================
See Notes to Consolidated Financial Statements
N-Viro International Corporation
Consolidated Statements of Cash Flows
(Unaudited)
Nine Months Ended September 30
------------------------------
2006 2005
---------- ----------
NET CASH PROVIDED BY OPERATING ACTIVITIES $ 173,896 $ 135,739
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property and equipment (320,838) (1,270)
Expenditures for intangible assets (3,414) (1,830)
Proceeds from the sale of property and equipment 9,800 -
Reductions to restricted cash and cash equivalents (2,493) (51,844)
Collections on notes receivable - 43,768
---------- ----------
Net cash used in investing activities (316,945) (11,176)
CASH FLOWS FROM FINANCING ACTIVITIES
Borrowings under long-term obligations 219,309 -
Issuance of stock - options, warrants and private placement - 130,000
Private placement expenditures - (3,180)
Principal payments on long-term obligations (67,262) (84,005)
Net payments on line-of credit (55,000) (150,000)
---------- ----------
Net cash provided by (used in) financing activities 97,047 (107,185)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (46,002) 17,378
CASH AND CASH EQUIVALENTS - BEGINNING 224,447 147,549
---------- ----------
CASH AND CASH EQUIVALENTS - ENDING $ 178,445 $ 164,927
========== ==========
Supplemental disclosure of cash flows information:
Cash paid during the nine months ended for interest $ 16,370 $ 32,459
========== ==========
See Notes to Consolidated Financial Statements
N-VIRO INTERNATIONAL CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. Organization and Basis of Presentation
The accompanying consolidated financial statements of N-Viro International
Corporation (the "Company") are unaudited but, in management's opinion, reflect
all adjustments (including normal recurring accruals) necessary to present
fairly such information for the period and at the dates indicated. The results
of operations for the nine months ended September 30, 2006 may not be indicative
of the results of operations for the year ending December 31, 2006. Since the
accompanying consolidated financial statements have been prepared in accordance
with Item 310 of Regulation S-B, they do not contain all information and
footnotes normally contained in annual consolidated financial statements;
accordingly, they should be read in conjunction with the consolidated financial
statements and notes thereto appearing in the Company's Form 10-KSB for the
period ending December 31, 2005.
The financial statements are consolidated as of September 30, 2006 and
December 31, 2005 for the Company. All intercompany transactions were
eliminated.
In preparing financial statements in conformity with accounting principles
generally accepted in the United States of America, management makes estimates
and assumptions that affect the reported amounts of assets and liabilities and
disclosures of contingent assets and liabilities at the date of the financial
statements, as well as the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates. The
following are certain significant estimates and assumptions made in preparation
of the financial statements:
Allowance for Doubtful Accounts - The Company estimates losses for
uncollectible accounts based on the aging of the accounts receivable and the
evaluation of the likelihood of success in collecting the receivable. The
balance of the allowance at September 30, 2006 and December 31, 2005 is $60,000
and $55,000, respectively.
Property and Equipment/Long-Lived Assets - Property and equipment is
reviewed for impairment pursuant to the provisions of Statement of Financial
Accounting Standards (or SFAS) No. 144, "Accounting for the Impairment or
Disposal of Long-Lived Assets." The carrying amount of an asset (group) is
considered impaired if it exceeds the sum of the Company's estimate of the
undiscounted future cash flows expected to result from the use and eventual
disposition of the asset (group), excluding interest charges. Property,
machinery and equipment are stated at cost less accumulated depreciation.
Management believes the carrying amount is not impaired based upon estimated
future cash flows.
Equity Method Investment - The Company accounts for its investments in
joint ventures under the equity method. The Company periodically evaluates the
recoverability of its equity investments in accordance with Accounting
Principals Board Opinion, or APB, Opinion No. 18, "The Equity Method of
Accounting for Investments in Common Stock." As of November 2005, the Company
had fully recognized it's share of the equity investment in it's joint venture
to the extent of its investment, including any Notes Receivable. After that
date, the Company has not recorded any additional loss even though the joint
venture has continued to sustain losses, because of a lack of basis in this
investment. The Company has no other investments accounted for under the equity
method.
Intangible Assets - Intangible assets deemed to have indefinite lives are
tested for impairment by comparing the fair value with its carrying value.
Significant estimates used in the determination of fair value include estimates
of future cash flows. As required under current accounting standards, the
Company tests for impairment when events and circumstances indicate that the
assets might be impaired and the carrying value of those assets may not be
recoverable. The Company is also amortizing the capitalized cost of obtaining
its credit facility, for the additional collateral required and evidenced by a
warrant to purchase 50,000 shares of the Company's common stock. The Company
estimated this cost at February 26, 2003 to be $30,000, and is amortizing this
over 4 years by the straight-line method.
Fair Value of Financial Instruments - The fair values of cash, accounts
receivable, accounts payable and other short-term obligations approximate their
carrying values because of the short maturity of these financial instruments.
The carrying values of the Company's long-term obligations approximate their
fair value. In accordance with SFAS No. 107, "Disclosure About Fair Value of
Financial Instruments," rates available at balance sheet dates to the Company
are used to estimate the fair value of existing debt.
Income Taxes - The Company assumes the deductibility of certain costs in
income tax filings and estimates the recovery of deferred income tax assets.
Stock Options - Through December 31, 2005, the Company accounted for
stock-based compensation issued to its employees and directors in accordance
with APB Opinion No. 25, "Accounting for Stock Issued to Employees."
Accordingly, no compensation cost was recognized through that period for the
stock option plans, as all options granted under the plans have an exercise
price equal to the market value of the underlying common stock on the date of
the grant, except for the options granted in May, 2004 to Michael Nicholson,
which is explained further in Note 4, "Contingencies". The fair value of
options granted was determined using the Black-Scholes option pricing model. In
December 2004, SFAS No. 123R, "Accounting for Stock-Based Compensation" was
issued and changed the accounting for transactions in which an entity obtains
employee services in a share-based payment transaction. For Small Business
issuers such as the Company, the Statement is effective as of the beginning of
the first interim period or annual reporting period that begins after December
15, 2005. The adoption of this standard is reflected in the current period by
the expensing of existing stock options granted in 2004 that vest through 2008
to current optionees, and options granted in the current period to directors for
a board meeting. The Company is uncertain as to any future grants in the
current year to employees or others that may be approved by the Board.
The following table illustrates the effect on net income (loss) and net income
(loss) per share if the Company had applied the fair value recognition
provisions of Financial Accounting Standards Board (or FASB) Statement No. 123,
"Accounting for Stock-based Compensation" to stock-based employee compensation:
Three Months Ended Sept. 30 Nine Months Ended Sept. 30
--------------------------- --------------------------
2006 2005 2006 2005
---------- ---------- ---------- ----------
Net loss, as reported $(157,273) $ (63,985) $(324,844) $(335,605)
Deduct: Total stock-based employee
compensation expense determined under
fair value based method for all awards,
net of related tax effects (2005 only) - (48,624) - (130,121)
---------- ---------- ---------- ----------
Pro forma net loss $(157,273) $(112,609) $(324,844) $(465,726)
========== ========== ========== ==========
Loss per share:
Basic and diluted - as reported $ (0.04) $ (0.02) $ (0.09) $ (0.10)
========== ========== ========== ==========
Basic and diluted - pro-forma $ (0.04) $ (0.03) $ (0.09) $ (0.13)
========== ========== ========== ==========
Note 2. Related Party Transactions
On March 1, June 1 and September 1, 2006, the Company successively issued
12,500 shares of unregistered common stock to Timothy Kasmoch, Chief Executive
Officer, pursuant to the terms of his employment agreement agreed to in
February, 2006. See Note 4, "Contingencies".
During the quarter and nine months ended September 30, 2006, the Company
contracted for trucking services with Gardenscape, a company that Mr. Kasmoch is
the President and CEO of, totaling $22,019 and $62,360, respectively. The trade
payable to Gardenscape at September 30, 2006 for these services was $16,983.
Note 3. Long-Term Debt
The Company presently has a $695,000 credit facility with Monroe Bank +
Trust, or the Bank. This senior debt credit facility is comprised of a $295,000
four year term note at 7.5% and a line of credit up to $400,000 at Prime (8.25%
at September 30, 2006) plus 1.5% and secured by a first lien on all assets of
the Company. Two certificates of deposit totaling $125,000 from the Bank are
held as a condition of maintaining the facility. The Company has currently
renewed the line of credit through October 2007, and is not in violation of any
financial covenants. At September 30, 2006, the Company had $375,000 of
borrowing capacity under the credit facility. The amount owed on the term note
as of September 30, 2006 was approximately $42,000 and this term note is
expected to be paid in full in March 2007.
In the third quarter 2006, the Company's wholly-owned subsidiary,
Bio-Mineral Transportation LLC, borrowed a total of $219,309 from Monroe Bank +
Trust, to purchase trucks and a trailer that were placed into service during the
quarter. A total of three term notes were issued, each at 8% for five years and
each secured by equipment. The total amount owed on the notes as of September
30, 2006 was approximately $212,000 and all are expected to be paid in full by
July 2011.
Note 4. Contingencies and Other Obligations to Related Parties
The Company leases its executive and administrative office in Toledo, Ohio,
under a lease that extends through February 2007. The Company believes its
relationship with its lessor is satisfactory. The total minimum rental
commitment for the three months ending December 31, 2006 and 2007 is
approximately $9,300 and $6,200, respectively. The total rental expense
included in the statements of operations for the nine months ended September 30,
2006 and 2005 is approximately $27,900 and $28,200, respectively. The Company
also leases various equipment on a month-to-month basis.
In March 2006, the Company's Board of Directors approved a Consulting
Agreement with DJH Holdings, LLC, a company owned by Daniel J. Haslinger, a
current member of the Board and up until February 14, 2006, the Company's Chief
Executive Officer. The consulting arrangement is for a six-month term, is
terminable by DJH Holdings, LLC upon fifteen (15) days notice or by us upon
ninety (90) days notice. Payments under the Consulting Agreement are $9,000 per
month. The Consulting Agreement is effective as of February 13, 2006. A copy
of the Consulting Agreement was attached to a Form 8-K as Exhibit 10.1, filed by
the Company March 20, 2006.
In March 2006, the Company's Board of Directors approved a Consulting
Agreement with Carl Richard, a current member of the Board. The term of the
Consulting Agreement is one (1) year, is terminable by Mr. Richard upon fifteen
(15) days notice or by us upon ninety (90) days notice. Payments under the
Consulting Agreement are $1,600 per month. The Consulting Agreement is
effective as of February 13, 2006. A copy of the Consulting Agreement was
attached to a Form 8-K as Exhibit 10.2, filed by the Company March 20, 2006.
In March 2006, the Company's Board of Directors approved a First Amendment
to a Consulting Agreement dated July 1, 2004 with Terry J. Logan, a current
member of the Board. The existing Consulting Agreement was scheduled to expire
on June 30, 2006, and was extended an additional two (2) years from that date.
The existing Consulting Agreement was filed as an exhibit to the Form 8-K filed
on July 2, 2004 by N-Viro International Corporation. All other terms of the
existing Consulting Agreement have been retained, with the exception of Section
5.4, referring to Dr. Logan's stock option compensation, which has been deleted
by the First Amendment. Dr. Logan will continue to be compensated at a base fee
of $87.50 per hour. The First Amendment to the Consulting Agreement is
effective as of February 13, 2006. A copy of the Consulting Agreement was
attached to a Form 8-K as Exhibit 10.3, filed by the Company March 20, 2006.
In February 2006, the Company executed an Employment Agreement with Timothy
R. Kasmoch. Mr. Kasmoch is now employed by the Company as President and Chief
Executive Officer, and is a member of the Company's Board of Directors. The
Company and Mr. Kasmoch agreed primarily to enter into an employment arrangement
which is for a one-year term, for $60,000 per year plus 50,000 unregistered
shares of stock in the Company. The Employment Agreement is terminable with or
without cause, and is effective at the date of agreement. A copy of the
Employment Agreement was attached to a Form 8-K as Exhibit 10.1, filed by the
Company February 21, 2006.
In June 2005, J. Patrick Nicholson filed a Demand for Arbitration, seeking
damages of $50,000 from the Company, based on a claimed breach of a Consulting
Agreement dated August 28, 2003 between the Company and Mr. Nicholson. Mr.
Nicholson also seeks rescission of his Consulting Agreement and reinstatement of
a prior agreement between him and the Company, which was in effect prior to the
order by the Delaware Chancery Court terminating a stockholder derivative suit.
This arbitration proceeding was previously reported in a Form 10-QSB filed by
the Company August 15, 2005. The Company is vigorously contesting Mr.
Nicholson's claims in this proceeding. Discovery is still in process, and a
hearing on the matter is likely to be scheduled for January 2007.
On July 13, 2005, the Company's Board of Directors voted to terminate for
cause the Consulting Agreement with J. Patrick Nicholson, based on numerous
specific instances of violations of the terms of the Consulting Agreement by
him. The Consulting Agreement, filed as Exhibit B to the Form 8-K filed August
29, 2003, contained a term ending no earlier than five years from the date of
the contract. Mr. Nicholson is a reporting beneficial owner of approximately
10.6% of the Company's outstanding common stock, as of the date of his Form SC
13D/A filed August 9, 2006. Mr. Nicholson was being paid an aggregate of over
$92,000 per year under the Consulting Agreement, exclusive of any other payouts
earnable. In November 2005, Mr. Nicholson filed an amended complaint pertaining
to his Demand for Arbitration, which added as an additional claim wrongful
termination.
On January 27, 2006, J. Patrick Nicholson applied to the Delaware Chancery
Court for an order to compel the Company to allow him access to inspect our
corporate and business books and records and our stockholder list, pursuant to a
request under Section 220 of the Delaware General Corporation Law. No monetary
relief is sought in this action. The Company contends that the documents sought
by Mr. Nicholson in this action far exceed those to which he is entitled under
Section 220, and principally relate to his claims in the arbitration described
above. The Company is vigorously defending this action and has filed a response
in the Delaware Chancery Court, but no discovery has been conducted, and no
relief has been granted as of the date of this Form 10-QSB.
On July 11, 2006, J. Patrick Nicholson and N-Viro Energy Systems, Inc.
filed a Complaint with Jury Demand in the United States District Court for the
Northern District of Ohio, against the Company, Ophir Holdings, Inc., Strategic
Asset Management, Inc., Robert A. Cooke, the Cooke Family Trust and the
following members of our Board of Directors: Daniel J. Haslinger, Phillip Levin,
R. Francis DiPrete and Terry J. Logan. The Complaint is seeking undeterminable
damages and other relief from the named defendants, based on a claimed breach of
fiduciary duty, common law fraud and violations of Section 10(b)(5) of the
Securities Exchange Act of 1934. N-Viro filed a motion to dismiss the lawsuit on
August 25, 2006. Before Mr. Nicholson responded to N-Viro's motion, Mr.
Nicholson's attorneys filed a motion to withdraw as counsel from the case. The
judge has given Mr. Nicholson until November 24, 2006 to find new counsel. If
Mr. Nicholson is able to find new counsel, the motion to withdraw will be
granted. The response to N-Viro's pending motion is due on December 22, 2006,
with a likely hearing date in January.
In June 2003, the Company entered into an Employment Agreement (the
"Agreement") with Michael G. Nicholson, the Chief Development Officer and a
member of the Board of Directors of the Company. The employment agreement will
expire in June 2007, and future compensation amounts are to be determined
annually by the Board of Directors. The agreement was disclosed in a filing on
June 10, 2003 on Form 8-K. In the third quarter of 2004, the Company and Mr.
Nicholson renegotiated primarily the stock option portion of the Agreement, and
amended the Agreement. Because these options were priced lower than the fair
market value as of that date, the Company is required to take a charge to
earnings totaling approximately $68,400 ratably through June, 2007, the ending
date of his employment agreement
The Company operates in an environment with many financial risks,
including, but not limited to, major customer concentrations, customer contract
termination provisions, competing technologies, infringement and/or
misappropriation of intellectual property rights, the highly competitive and, at
times, seasonal nature of the industry and worldwide economic conditions.
Various federal, state and governmental agencies are considering, and some have
adopted, laws and regulations regarding environmental protection which could
adversely affect the business activities of the Company. The Company cannot
predict what effect, if any, current and future regulations may have on the
operations of the Company.
Note 5. New Accounting Standards
In September 2006, the Financial Accounting Standards Board issued
Statement of Accounting Standards No. 157, "Fair Value Measurements", which
provides enhanced guidance for using fair value to measure assets and
liabilities, and also responds to investors' requests for expanded information
about the extent to which companies measure assets and liabilities at fair
value, the information used to measure fair value, and the effect of fair value
measurements on earnings. The Statement applies whenever other standards
require (or permit) assets or liabilities to be measured at fair value, but does
not expand the use of fair value in any new circumstances. The Statement is
effective for fiscal years beginning after November 15, 2007, and interim
periods within those fiscal years. The Company does not expect the application
of the provisions of Standard No. 157 to have a material impact on its financial
position, results of operations or cash flows.
In September 2006, the Financial Accounting Standards Board issued
Statement of Accounting Standards No. 158, "Employers' Accounting for Defined
Benefit Pension and Other Postretirement Plans", and is an amendment to FASB
Statements No. 87, 88, 106 and 132R. This Statement requires employers to fully
recognize the obligations associated with single-employer defined benefit
pension, retiree healthcare and other postretirement plans in their financial
statements. The standard will make it easier for investors, employees, retirees
and others to understand and assess an employer's financial position and its
ability to fulfill the obligations under its benefit plans, and applies to plan
sponsors that are public and private companies and nongovernmental
not-for-profit organizations. A requirement to recognize the funded status of a
benefit plan and the disclosure requirements is effective as of the end of the
fiscal year ending after December 15, 2006, for entities with publicly traded
equity securities, and at the end of the fiscal year ending after June 15, 2007,
for all other entities. A requirement to measure plan assets and benefit
obligations as of the date of the employer's fiscal year-end statement of
financial position is effective for fiscal years ending after December 15, 2008.
The Company does not expect the application of the provisions of Standard No.
158 to have a material impact on its financial position, results of operations
or cash flows.
Note 6. Segment Information
Earnings Variation Due to Business Cycles and Seasonal Factors. The
Company's operating results can experience quarterly or annual variations due to
business cycles, seasonality and other factors. The market price for its common
stock may decrease if its operating results do not meet the expectations of the
market.
For the third quarter of 2006, approximately 50% of the Company's revenue
is from management operations, 46% from other domestic operations, 4% from
foreign sources and 0% from research and development grants. Sales of the
N-Viro technology are affected by general fluctuations in the business cycles in
the United States and worldwide, instability of economic conditions (such as the
current conditions in the Asia Pacific region and Latin America) and interest
rates, as well as other factors. In addition, operating results of some of the
Company's business segments are influenced by particular business cycles and
seasonality, as well as other factors such as interest rates.
Competition. The Company conducts business in a highly competitive market
and has fewer resources than most of its competitors. Businesses in this market
compete within and outside the United States principally on the basis of price,
product quality, custom design, technical support, reputation, equipment
financing assistance and reliability. Competitive pressures and other factors
could cause the Company to lose market share or could result in decreases in
prices, either of which could have a material adverse effect on its financial
position and results of operations.
Risks of Doing Business in Other Countries. The Company conducts business
in markets outside the United States, and expects to continue to do so. In
addition to the risk of currency fluctuations, the risks associated with
conducting business outside the United States include: social, political and
economic instability; slower payment of invoices; underdeveloped infrastructure;
underdeveloped legal systems; and nationalization. The Company has not entered
into any currency swap agreements which may reduce these risks. The Company may
enter into such agreements in the future if it is deemed necessary to do so.
Current economic and political conditions in the Asia Pacific and Middle East
regions have affected the Company outlook for potential revenue there. The
Company cannot predict the full impact of this economic instability, but it
could have a material adverse effect on revenues and profits.
The Company has determined that its reportable segments are those that are
based on the Company's method of internal reporting, which segregates its
business by product category and service lines. The Company's reportable
segments are as follows:
Management Operations - The Company provides employee and management
services to operate the Toledo Wastewater Treatment Facility.
Other Domestic Operations - Sales of territory or site licenses and
royalty fees to use N-Viro technology in the United States.
Foreign Operations - Sale of territory or site licenses and royalty
fees to use N-Viro technology in foreign operations.
Research and Development - The Company contracts with Federal and
State agencies to perform or assist in research and development on the Company's
technology.
The accounting policies of the segments are the same as the Company's
significant accounting policies. Fixed assets generating specific revenue are
identified with their respective segments and are accounted for as such in the
internal accounting records. All other assets, including cash and other current
assets and all long-term assets, other than fixed assets, are not identified
with any segments, but rather the Company's administrative functions. All of
the net nonoperating income (expense) are non-apportionable and not allocated to
a specific segment. The Company accounts for and analyzes the operating data
for its segments generally by geographic location, with the exception of the
Management Operations and Research and Development segments. The Management
Operations segment represents both a significant amount of business generated as
well as a specific location and unique type of revenue.
The domestic and foreign operations segments differ in terms of
environmental and municipal legal issues, nature of the waste disposal
infrastructure, political climate and availability of funds for investing in the
Company's technology. These factors have not changed significantly over the
past several years and are not expected to change in the near term.
The Research and Development segment accounts for approximately 3% of the
total year-to-date revenue of the Company, and is unlike any other revenue in
that it is generated as a result of a specific project to conduct initial or
additional ongoing research into the Company's emerging technologies.
The table below presents information about the segment profits and segment
identifiable assets used by the chief operating decision makers of the Company
for the periods ended September 30, 2006 and 2005 (dollars in thousands):
Management Domestic Foreign Research &
Operations Operations Operations Development Total
------------------------------------- ----------- ------------ ------------ ------
Quarter Ended September 30, 2006
--------------------------------------------------------------------------------------
Revenues $ 447 $ 408 $ - $ 30 $ 885
Cost of revenues 269 298 9 21 597
Segment profits 178 110 (9) 9 288
Identifiable assets 484 102 - - 586
Depreciation 20 10 - - 30
Quarter Ended September 30, 2005
--------------------------------------------------------------------------------------
Revenues $ 397 $ 528 $ - $ 23 $ 948
Cost of revenues 277 390 3 19 689
Segment profits 120 138 (3) 4 259
Identifiable assets 244 52 - - 296
Depreciation 14 3 - - 17
Nine Months Ended September 30, 2006
--------------------------------------------------------------------------------------
Revenues $ 1,332 $ 1,378 $ 66 $ 90 $2,866
Cost of revenues 743 1,002 1 82 1,828
Segment profits 589 376 65 8 1,038
Identifiable assets 484 102 - - 586
Depreciation 54 16 - - 70
Nine Months Ended September 30, 2005
--------------------------------------------------------------------------------------
Revenues $ 1,077 $ 1,945 $ 13 $ 68 $3,103
Cost of revenues 763 1,431 10 57 2,261
Segment profits 314 514 3 11 842
Identifiable assets 244 52 - - 296
Depreciation 44 11 - - 55
A reconciliation of total segment revenues, cost of revenues, and segment
profits to consolidated revenues, cost of revenues, and segment information to
the consolidated financial statements for the periods ended September 30, 2006
and 2005 is as follows (dollars in thousands):
Qtr. Ended Nine Months Ended
Sept. 30 Sept. 30
---------------- ------------------
2006 2005 2006 2005
------- ------- -------- --------
Segment profits:
Segment profits for reportable segments $ 288 $ 259 $ 1,038 $ 842
Corporate selling, general and administrative expenses (445) (288) (1,358) (1,005)
Other income (expense) (1) (35) (5) (173)
------- ------- -------- --------
Consolidated loss before taxes $ (158) $ (64) $ (325) $ (336)
======= ======= ======== ========
Identifiable assets:
Identifiable assets for reportable segments $ 586 $ 296 $ 586 $ 296
Corporate property and equipment 20 8 20 8
Current assets not allocated to segments 1,052 1,522 1,052 1,522
Intangible and other assets not allocated to
segments 814 1,151 814 1,151
Consolidated assets $2,472 $2,977 $ 2,472 $ 2,977
======= ======= ======== ========
Depreciation and amortization:
Depreciation for reportable segments $ 30 $ 17 $ 70 $ 55
Corporate depreciation and amortization 35 37 105 112
------- ------- -------- --------
Consolidated depreciation and amortization $ 65 $ 54 $ 175 $ 167
======= ======= ======== ========
Note 7. Investment in Florida N-Viro, L. P.
Florida N-Viro, L.P. was formed in January 1996 pursuant to a joint venture
agreement between the Company and VFL Technology Corporation (VFL). The Company
owns a 47.5% interest in the joint venture and accounts for its investment under
the equity method. The Company has recognized its share of the joint venture's
losses to the extent of its investment. Additional losses passed through from
the joint venture were recorded as an increase to the allowance against the Note
Receivable, through November 2005, when the total losses matched the value of
the Notes. After that date, the Company has not recorded any additional loss
even though Florida N-Viro continued to sustain losses, because of a lack of
basis in this investment.
Condensed financial information of Florida N-Viro, L.P. for the quarters
ended September 30, 2006 and 2005 is as follows:
For the Quarter Ended Sept. 30
------------------------------
2006 2005
--------- ---------
Net sales $286,433 $293,830
Gross profit (loss) (53,918) (36,292)
Loss from continuing operations (94,245) (67,490)
Net loss (94,245) (67,490)
Item 2. Management's Discussion and Analysis or Plan of Operation
Forward-Looking Statements
This 10-QSB contains statements that are forward-looking. We caution that
words used in this document such as "expects," "anticipates," "believes," "may,"
and "optimistic," as well as similar words and expressions used herein, identify
and refer to statements describing events that may or may not occur in the
future. These forward-looking statements and the matters to which they refer
are subject to considerable uncertainty that may cause actual results to be
materially different from those described herein. There are numerous factors
that could cause actual results to be different than those anticipated or
predicted by us, including: (i) a deterioration in economic conditions in
general; (ii) a decrease in demand for our products or services in particular;
(iii) our loss of a key employee or employees; (iv) regulatory changes,
including changes in environmental regulations, that may have an adverse affect
on the demand for our products or services; (v) increases in our operating
expenses resulting from increased costs of labor and/or consulting services; and
(vi) a failure to collect upon or otherwise secure the benefits of existing
contractual commitments with third parties, including our customers. This list
provides examples of factors that could affect the results described by
forward-looking statements contained in this Form 10-QSB; however, this list is
not exhaustive and many other factors could impact the Company's business and it
is impossible to predict with any accuracy which factors could result in
negative impacts. Although we believe that the forward-looking statements
contained in this Form 10-QSB are reasonable, we cannot provide you with any
guarantee that the anticipated results will not be adverse and that the
anticipated results will be achieved. All forward-looking statements in this
Form 10-QSB are expressly qualified in their entirety by the cautionary
statements contained in this section and you are cautioned not to place undue
reliance on the forward-looking statements contained in this Form 10-QSB. In
addition to the risks listed above, other risks may arise in the future, and we
disclaim any obligation to update information contained in any forward-looking
statement.
Overview
We incorporated in April, 1993, and became a public company on October 12,
1993. Our business strategy is to market the N-Viro Process, which produces a
sludge product with multiple commercial uses having an "exceptional quality" as
defined in the Section 503 Sludge Regulations under the Clean Water Act of 1987.
To date, our revenues have been derived primarily from the licensing of the
N-Viro Process to treat and recycle wastewater sludge generated by municipal
wastewater treatment plants and from the sale to licensees of the alkaline
admixture used in the N-Viro Process. We also operate N-Viro facilities for
third parties on a start-up basis and currently operate one N-Viro facility on a
contract management basis.
Results of Operations
Total revenues were $885,000 for the quarter ended September 30, 2006
compared to $948,000 for the same period of 2005. The net decrease in revenue
is due primarily to a decrease in alkaline admixture sales and service fees and,
a decrease in miscellaneous revenue. Our cost of revenues decreased to $597,000
in 2006 from $689,000 for the same period in 2005, and the gross profit
percentage increased to 33% from 27% for the quarters ended September 30, 2006
and 2005, respectively. This increase in gross profit percentage is primarily
due to the increased profitability of the facility management fee operations.
Operating expenses increased for the comparative period, while our share of the
loss of a joint venture, our interest in Florida N-Viro, L.P., decreased for the
same period of 2006. These changes collectively resulted in a net loss of
approximately $157,000 for the quarter ended September 30, 2006 compared to a
net loss of $64,000 for the same period in 2005, an increase in the net loss of
approximately $93,000.
Comparison of Three Months Ended September 30, 2006 with Three Months Ended
September 30, 2005
Our overall revenue decreased $63,000, or 7%, to $885,000 for the quarter
ended September 30, 2006 from $948,000 for the quarter ended September 30, 2005.
The net decrease in revenue was due primarily to the following:
a) Sales of alkaline admixture decreased $50,000 from the same period
ended in 2005;
b) Revenue from the service fees for the management of alkaline admixture
decreased $74,000 from the same period ended in 2005;
c) Our processing revenue, including facility management revenue, showed a
net increase of $77,000 over the same period ended in 2005;
d) Miscellaneous revenues decreased $23,000 from the same period ended in
2005; and
e) Research and development revenue increased $7,000 from the same period
ended in 2005.
Our gross profit increased $29,000, or 11%, to $288,000 for the quarter
ended September 30, 2006 from $259,000 for the quarter ended September 30, 2005,
and the gross profit margin increased to 33% from 27% for the same periods. The
increase in gross profit margin is primarily due to the increase in
profitability of the facility management fee operations, as payroll-related
costs associated with this operation in 2005 are accounted for in operating
expenses for the same quarter in 2006.
Our operating expenses increased $157,000, or 55%, to $445,000 for the
quarter ended September 30, 2006 from $288,000 for the quarter ended September
30, 2005. The increase was primarily due to an increase of approximately
$105,000 in employee payroll and related expenses, $34,000 in legal fees,
$35,000 in consulting expense and $15,000 in director-related expenses. The
increase in operating expenses was partially offset by a decrease of $17,000 in
travel and sales-related expenses. Of the overall increase in operating
expenses of $157,000 for the quarter ended, approximately $50,000 was from
issuing stock or stock options as payment, of which $20,000 was from the change
in the rules for accounting - See Note 1 "Stock Options", in Part I Notes to
Consolidated Financial Statements.
As a result of the foregoing factors, we recorded an operating loss of
$156,000 for the quarter ended September 30, 2006 compared to an operating loss
of $29,000 for the quarter ended September 30, 2005, an increase in the loss of
approximately $128,000.
Our net nonoperating expense decreased by $34,000 to net nonoperating
expense of $1,000 for the quarter ended September 30, 2006 from net nonoperating
expense of $35,000 for the quarter ended September 30, 2005. The decrease in
nonoperating expense was primarily due to a reduction in the recognition of
losses from our investment in Florida N-Viro, L.P., to a loss of $-0- in 2006
from a loss of $32,000 in 2005.
We recorded net loss of approximately $157,000 for the quarter ended
September 30, 2006 compared to a net loss of $64,000 for the same period ended
in 2005, an increase in the loss of approximately $93,000.
For the quarter ended September 30, 2006 and 2005, we have not fully
recognized the tax benefit of the losses incurred in prior periods.
Accordingly, our effective tax rate for each period was zero.
Comparison of Nine Months Ended September 30, 2006 with Nine Months Ended
September 30, 2005
Our overall revenue decreased $236,000, or 8%, to $2,866,000 for the nine
months ended September 30, 2006 from $3,102,000 for the nine months ended
September 30, 2005. The net decrease in revenue was due primarily to the
following:
a) Sales of alkaline admixture decreased $195,000 from the same period
ended in 2005;
b) Revenue from the service fees for the management of alkaline admixture
decreased $283,000 from the same period ended in 2005;
c) Our processing revenue, including facility management revenue, showed a
net increase of $282,000 over the same period ended in 2005;
d) Miscellaneous revenues decreased $63,000 from the same period ended in
2005; and
e) Research and development revenue increased $23,000 from the same period
ended in 2005.
Our gross profit increased $196,000, or 23%, to $1,038,000 for the nine
months ended September 30, 2006 from $842,000 for the nine months ended
September 30, 2005, and the gross profit margin increased to 36% from 27% for
the same periods. The increase in gross profit margin is primarily due to the
increase in approximately $66,000 of foreign royalty fee revenue at virtually no
cost, and increased profitability of the facility management fee operations.
The foreign source royalty fee represents past royalties due from a licensee for
the years 2002 through 2006, but will not be collected from the licensee in the
future. The increase in profitability from the management fee operations was
partially due to a shutdown for part of the second quarter ended in 2005 not
repeated in the same quarter in 2006, and payroll-related costs associated with
this operation in 2005 are accounted for in operating expenses in 2006.
Our operating expenses increased $353,000, or 35%, to $1,358,000 for the
nine months ended September 30, 2006 from $1,005,000 for the nine months ended
September 30, 2005. The increase was primarily due to an increase of
approximately $197,000 in employee payroll and related expenses, $112,000 in
legal fees, $16,000 in the write-off of fixed assets abandoned during the
quarter, $55,000 in consulting expense, $30,000 in director-related expense and
$13,000 in travel and sales-related expense. Of the overall increase in
operating expenses of $353,000, approximately $154,000 was from issuing stock or
stock options as payment, of which $57,000 was from the change in the rules for
accounting - See Note 1 "Stock Options", in Part I Notes to Consolidated
Financial Statements. The increase in operating expenses was partially offset
by a decrease of $31,000 in stockholder relations fees, as a result of deferring
the annual meeting until November, 2006.
As a result of the foregoing factors, we recorded an operating loss of
$320,000 for the nine months ended September 30, 2006 compared to an operating
loss of $163,000 for the nine months ended September 30, 2005, an increase in
the loss of approximately $157,000.
Our net nonoperating expense decreased by $167,000 to net nonoperating
expense of $5,000 for the nine months ended September 30, 2006 from net
nonoperating expense of $173,000 for the nine months ended September 30, 2005.
The decrease in nonoperating expense was primarily due to a reduction in the
recognition of losses from our investment in Florida N-Viro, L.P., to a loss of
$-0- in 2006 from a loss of $156,000 in 2005.
We recorded net loss of approximately $325,000 for the nine months ended
September 30, 2006 compared to a net loss of $336,000 for the same period ended
in 2005, a decrease in the loss of approximately $11,000.
For the nine months ended September 30, 2006 and 2005, we have not fully
recognized the tax benefit of the losses incurred in prior periods.
Accordingly, our effective tax rate for each period was zero.
Liquidity and Capital Resources
We had a working capital deficit of approximately $98,000 at September 30,
2006, compared to a working capital deficit of $41,000 at December 31, 2005,
resulting in a decrease in working capital of $57,000. Current assets at
September 30, 2006 included cash and investments of approximately $309,000
(including restricted cash of approximately $131,000), which is a decrease of
$44,000 from December 31, 2005.
Our cash flow provided by operations for the first nine months ended
September 30, 2006, was approximately $174,000, an increase of approximately
$38,000 from the same period in 2005. This increase was principally due to the
increase of non-cash items of approximately $39,000.
We presently have a $695,000 credit facility with Monroe Bank + Trust, or
the Bank. This senior debt credit facility is comprised of a $295,000 four year
term note at 7.5% and a line of credit up to $400,000 at Prime (8.25% at
September 30, 2006) plus 1.5% and secured by a first lien on all of our assets.
Two certificates of deposit totaling $125,000 from the Bank are held as a
condition of maintaining the facility. We have currently renewed the line of
credit through October 2007, and are not in violation of any financial
covenants. At September 30, 2006, we had $375,000 of borrowing capacity
available under the credit facility. The amount owed on the term note as of
September 30, 2006 was approximately $42,000 and we expect to pay it in full by
March 2007.
In the third quarter 2006, our wholly-owned subsidiary, Bio-Mineral
Transportation LLC, borrowed a total of $219,309 from Monroe Bank + Trust, to
purchase trucks and a trailer that were placed into service during the quarter.
A total of three term notes were issued, each at 8% for five years and each
secured by equipment. The total amount owed on the notes as of September 30,
2006 was approximately $212,000 and all are expected to be paid in full by July
2011.
The normal collection period for accounts receivable is approximately 30-60
days for the majority of customers. This is a result of the nature of the
license contracts, type of customer and the amount of time required to obtain
the information to prepare the billing.
We are currently in discussions with several companies in the cement and
fuel industries for the development and commercialization of the patented N-Viro
fuel technology. There can be no assurance that these discussions will be
successful.
We continue to focus on the development of regional biosolids processing
facilities. Currently we are in negotiations with several privatization firms
to permit and develop independent, regional facilities.
We expect improvements in operating results for the balance of 2006 and
into 2007 partially due to realized and expected new sources of revenue.
Additionally, market developments and ongoing discussions with companies in the
fuel and wastewater industries could provide enhanced liquidity and positively
impact 2006 and 2007 operations.
We believe that current market trends and increased and more focused
emphasis on our business development efforts provide a basis for an optimistic
outlook for 2006 and beyond. The national public attack on Class B levels of
sludge treatment is rapidly moving the market to Class A technologies, of which
our patented N-Viro processes are very cost competitive, and well established in
the market place. There are currently over 35 facilities worldwide using the
N-Viro Process, most of which have been using the N-Viro process for over 10
years. The development and patenting of new technologies for animal manure
treatment, bio-fuel and nematode control have the potential to expand our
revenue base over the next five years and beyond. We believe we have sufficient
liquidity to continue operations over the next twelve months.
Off-Balance Sheet Arrangements
At September 30, 2006, we did not have any material commercial commitments,
including guarantees or standby repurchase obligations, or any relationships
with unconsolidated entities or financial partnerships, including entities often
referred to as structured finance or special purpose entities or variable
interest entities, which would have been established for the purpose of
facilitating off-balance sheet arrangements or other contractually narrow or
limited purposes.
From time to time, during the normal course of business, we may make
certain indemnities, commitments and guarantees under which we may be required
to make payments in relation to certain transactions. These include: (i)
indemnities to vendors and service providers pertaining to claims based on our
negligence or willful misconduct and (ii) indemnities involving the accuracy of
representations and warranties in certain contracts. Pursuant to Delaware law,
we may indemnify certain officers and directors for certain events or
occurrences while the officer or director is, or was, serving at our request in
such capacity. We also have director and officer insurance coverage that limits
our exposure and enables us to recover a portion of any future amounts that we
may pay for indemnification purposes. We believe the applicable insurance
coverage is generally adequate to cover any estimated potential liability for
which we may provide indemnification. The majority of these indemnities,
commitments and guarantees do not provide for any limitation of the maximum
potential for future payments we could be obligated to make. We have not
recorded any liability for these indemnities, commitments and other guarantees
in the accompanying Consolidated Balance Sheets.
Contractual Obligations
The following table summarizes our contractual cash obligations at
September 30, 2006, and the effect these obligations are expected to have on
liquidity and cash flow in future periods:
Payments Due By Period
Note # Total Less than 1 year 1 - 3 years 4 - 5 years after 5 years
------- -------- ----------------- ------------ ------------ --------------
Purchase obligations (1) $134,600 $ 80,000 $ 54,600 $ - $ -
Long-term debt obligations (2) 254,115 79,710 133,152 41,253 -
Operating leases (3) 26,383 24,133 2,250 - -
Capital lease obligations - - - - -
Other long-term debt obligations - - - - -
-------- ----------------- ------------ ------------ --------------
Total contractual cash obligations $415,098 $ 183,843 $ 190,002 $ 41,253 $ -
======== ================= ============ ============ ==============
<FN>
(1) Purchase obligations include agreements to purchase services that are enforceable and legally
binding on the Company and that specify all significant terms and the approximate timing of the
transaction. Purchase obligations exclude agreements that are cancelable without penalty.
(2) Amounts represent the expected cash payments of our long-term obligations.
(3) Amounts represent the expected cash payments of our operating lease obligations.
Item 3. Controls and Procedures
Disclosure Controls and Procedures
As of September 30, 2006, under the direction of our Chief Executive
Officer and Chief Financial Officer, we evaluated the effectiveness of the
design and operation of our disclosure controls and procedures, as defined in
Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as
amended. We concluded that our disclosure controls and procedures were
effective as of September 30, 2006, such that the information required to be
disclosed in our SEC reports is recorded, processed, summarized and reported
within the time periods specified by the SEC's rules and forms, and is
accumulated and communicated to management, including our Chief Executive
Officer and Chief Financial Officer, as appropriate to allow timely decisions
regarding required disclosure.
Internal Controls
There were no changes in our internal controls over financial reporting
during the quarter ended September 30, 2006 that have materially affected, or
are reasonably likely to materially affect, our internal controls over financial
reporting.
PART II - OTHER INFORMATION
Item 1. Legal proceedings
In June 2005, J. Patrick Nicholson filed a Demand for Arbitration, seeking
damages of $50,000 from the Company, based on a claimed breach of a Consulting
Agreement dated August 28, 2003 between the Company and Mr. Nicholson. Mr.
Nicholson also seeks rescission of his Consulting Agreement and reinstatement of
a prior agreement between him and the Company, which was in effect prior to the
order by the Delaware Chancery Court terminating a stockholder derivative suit.
This arbitration proceeding was previously reported in a Form 10-QSB filed by
the Company August 15, 2005. The Company is vigorously contesting Mr.
Nicholson's claims in this proceeding. Discovery is still in process, and a
hearing on the matter is likely to be scheduled for January 2007.
On July 13, 2005, the Company's Board of Directors voted to terminate for
cause the Consulting Agreement with J. Patrick Nicholson, based on numerous
specific instances of violations of the terms of the Consulting Agreement by
him. The Consulting Agreement, filed as Exhibit B to the Form 8-K filed August
29, 2003, contained a term ending no earlier than five years from the date of
the contract. Mr. Nicholson is a reporting beneficial owner of approximately
10.6% of the Company's outstanding common stock, as of the date of his Form SC
13D/A filed August 9, 2006. Mr. Nicholson was being paid an aggregate of over
$92,000 per year under the Consulting Agreement, exclusive of any other payouts
earnable. In November 2005, Mr. Nicholson filed an amended complaint pertaining
to his Demand for Arbitration, which added as an additional claim wrongful
termination.
On January 27, 2006, J. Patrick Nicholson applied to the Delaware Chancery
Court for an order to compel the Company to allow him access to inspect our
corporate and business books and records and our stockholder list, pursuant to a
request under Section 220 of the Delaware General Corporation Law. No monetary
relief is sought in this action. The Company contends that the documents sought
by Mr. Nicholson in this action far exceed those to which he is entitled under
Section 220, and principally relate to his claims in the arbitration described
above. The Company is vigorously defending this action and has filed a response
in the Delaware Chancery Court, but no discovery has been conducted, and no
relief has been granted as of the date of this Form 10-QSB.
On July 11, 2006, J. Patrick Nicholson and N-Viro Energy Systems, Inc.
filed a Complaint with Jury Demand in the United States District Court for the
Northern District of Ohio, against the Company, Ophir Holdings, Inc., Strategic
Asset Management, Inc., Robert A. Cooke, the Cooke Family Trust and the
following members of our Board of Directors: Daniel J. Haslinger, Phillip
Levin, R. Francis DiPrete and Terry J. Logan. The Complaint is seeking
undeterminable damages and other relief from the named defendants, based on a
claimed breach of fiduciary duty, common law fraud and violations of Section
10(b)(5) of the Securities Exchange Act of 1934. N-Viro filed a motion to
dismiss the lawsuit on August 25, 2006. Before Mr. Nicholson responded to
N-Viro's motion, Mr. Nicholson's attorneys filed a motion to withdraw as counsel
from the case. The judge has given Mr. Nicholson until November 24, 2006 to
find new counsel. If Mr. Nicholson is able to find new counsel, the motion to
withdraw will be granted. The response to N-Viro's pending motion is due on
December 22, 2006, with a likely hearing date in January 2007.
From time to time we are involved in legal actions arising in the ordinary
course of business. With respect to these matters, we believe we have adequate
legal defenses and/or provided adequate accruals for related costs such that the
ultimate outcome will not have a material adverse effect on our future financial
position or results of operations.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
On September 1, 2006, we issued 12,500 shares of unregistered common stock
to Timothy Kasmoch, Chief Executive Officer, pursuant to the terms of his
employment agreement of February, 2006. See Note 4, "Contingencies".
Item 3. Defaults Upon Senior Securities
None
Item 4. Submission of Matters to a Vote of Security Holders
None
Item 5. Other Information
(a) None
Item 6. Exhibits
Exhibits:
See Exhibit Index below.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
N-VIRO INTERNATIONAL CORPORATION
Date: November 9, 2006 /s/ Timothy R. Kasmoch
---------------- -----------------------
Timothy R. Kasmoch
Chief Executive Officer and President
(Principal Executive Officer)
Date: November 9, 2006 /s/ James K. McHugh
---------------- ---------------------
James K. McHugh
Chief Financial Officer, Secretary and Treasurer
(Principal Financial & Accounting Officer)
EXHIBIT INDEX
Exhibit No. Document
----------- --------
3.1 Amended and Restated Certificate of Incorporation, dated June 17, 1998
(incorporated by reference to Exhibit 3.2 to Form 10-K filed April 14, 2004).
3.2 Amendment to the Certificate of Incorporation of the Company, dated
November 13, 2003 (incorporated by reference to Exhibit 3.4 to Form 10-K filed
April 14, 2004).
3.3 Amended and Restated By-Laws of the Company, dated May 13, 2005
(incorporated by reference to Exhibit 3.3 to Form 10-QSB filed May 16, 2005).
3.4 Amendment to the Certificate of Incorporation of the Company, dated July
6, 2005 (incorporated by reference to Exhibit 3.4 to Form 10-QSB filed August
15, 2005).
3.5 Text of amendment to the Amended and Restated By-Laws of the Company,
dated May 13, 2005 (incorporated by reference to Exhibit 99.1 to Form 10-K filed
April 14, 2004).
3.6 Amended and Restated By-Laws of the Company, dated January 27, 2006
(incorporated by reference to Exhibit 3.2 to Form 8-K filed February 2, 2006).
10.1 Employment Agreement, dated June 14, 1999, between N-Viro International
Corporation and Terry J. Logan (incorporated by reference to Exhibit 1 to the
Form 8-K filed June 30, 1999).*
10.2 Amended and Restated Employment Agreement, dated June 6, 2003, between
N-Viro International Corporation and Michael G. Nicholson (incorporated by
reference to Exhibit 99.1 to the Form 8-K filed June 9, 2003).*
10.3 Business Loan Agreement dated February 26, 2003, between N-Viro
International Corporation and Monroe Bank + Trust; letter of credit enhancement
dated February 25, 2003 between N-Viro International Corporation and Messrs. J.
Patrick Nicholson, Michael G. Nicholson, Robert P. Nicholson and Timothy J.
Nicholson (all incorporated by reference to Exhibits 99.1 through 99.3 to the
Form 8-K filed March 3, 2003).
10.4 Settlement Agreement and Release dated August 29, 2003 between N-Viro
International Corporation and Strategic Asset Management, Inc.; Consulting
Agreement dated August 28, 2003 between N-Viro International Corporation and J.
Patrick Nicholson (all incorporated by reference to Item 5, Exhibit A and
Exhibit B of the Form 8-K filed August 29, 2003).
10.5 Financial Public Relations Agreement dated September 15, 2005 between
Strategic Asset Management, Inc. and N-Viro International Corporation
(incorporated by reference to Exhibit 10.1 of Form 8-K dated October 12, 2005).
10.6 Warrant to Purchase 120,000 Shares of Common Stock dated September 15,
2005 between Strategic Asset Management, Inc. and N-Viro International
Corporation (incorporated by reference to Exhibit 10.2 of Form 8-K dated October
12, 2005).
10.7 Employment Agreement, executed February 17, 2006 between Timothy R.
Kasmoch and N-Viro International Corporation (incorporated by reference to
Exhibit 10.1 to Form 8-K filed February 21, 2006).*
10.8 Consulting Agreement between DJH Holdings, LLC and N-Viro International
Corporation, effective February 13, 2006 (incorporated by reference to Exhibit
10.1 to Form 8-K filed March 20, 2006).*
10.9 Consulting Agreement between Carl Richard and N-Viro International
Corporation, effective February 13, 2006 (incorporated by reference to Exhibit
10.2 to Form 8-K filed March 20, 2006).*
10.10 First Amendment to Consulting Agreement dated July 1, 2004 between
Terry J. Logan and N-Viro International Corporation, effective February 13, 2006
(incorporated by reference to Exhibit 10.3 to Form 8-K filed March 20, 2006).*
31.1 Certification of CEO Pursuant to Section 302 of the Sarbanes - Oxley
Act of 2002.
31.2 Certification of CFO Pursuant to Section 302 of the Sarbanes - Oxley
Act of 2002.
32.1 Certification of CEO Pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002.
32.2 Certification of CFO Pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002.
* Indicates a management contract or compensatory plan or arrangement.